Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 25,103 | 26,641 | 29,631 | 30,640 | 22,968 |
| Operating Income | -25,103 | -26,641 | -29,631 | -30,640 | -22,968 |
| Other Income | -8,457 | 593 | -138 | 1,615 | 7,074 |
| Pre-tax Income | -33,560 | -26,048 | -29,769 | -29,025 | -15,894 |
| Net Income Continuous | -33,560 | -26,048 | -29,769 | -29,025 | -15,894 |
| Net Income | $-33,560 | $-26,048 | $-29,769 | $-29,025 | $-15,894 |
| EPS Basic Total Ops | -28.42 | -189.14 | -376.75 | -5,704.65 | -221.14 |
| EPS Basic Continuous Ops | -28.33 | -189.14 | -376.71 | -5,704.86 | -221.66 |
| EPS Diluted Total Ops | -28.42 | -189.14 | -376.75 | -5,704.65 | -221.14 |
| EPS Diluted Continuous Ops | -28.33 | -189.14 | -376.71 | -5,704.86 | -221.66 |
| EPS Diluted Before Non-Recurring Items | -11.02 | -158.00 | -376.75 | -378.56 | -314.84 |
| EBITDA(a) | $-25,013 | $-26,515 | $-29,504 | $-30,510 | $-22,804 |